First CAR-T therapy to target BCMA gets FDA nod

被引：14
|
作者：
机构：
来源：
Nature Biotechnology | 2021年 / 39卷 / 5期
关键词：
D O I：
10.1038/s41587-021-00929-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 531
相关论文
共 50 条
  • [1] FDA approves first BCMA-targeted CAR-T cell therapy
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (05) : 332 - 332
  • [2] FDA approves first BCMA-targeted CAR-T cell therapy
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 332 - 332
  • [3] FDA approves second BCMA-targeted CAR-T cell therapy
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) : 249 - 249
  • [4] FDA approves second BCMA-targeted CAR-T cell therapy
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 249 - 249
  • [5] First CAR-T cell therapy of cancer was approved by FDA
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (10) : 2202 - 2202
  • [6] Innovation in BCMA CAR-T therapy: Building beyond the Model T
    Banerjee, Rahul
    Lee, Sarah S.
    Cowan, Andrew J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma
    Jin, Chengwei
    Deng, Jing
    Jiang, Ying
    Zhu, Jun
    Kang, Liqing
    Li, Su
    HEMATOLOGY, 2025, 30 (01)
  • [8] Target selection for CAR-T therapy
    Wei, Jianshu
    Han, Xiao
    Bo, Jian
    Han, Weidong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [9] Target selection for CAR-T therapy
    Jianshu Wei
    Xiao Han
    Jian Bo
    Weidong Han
    Journal of Hematology & Oncology, 12
  • [10] FDA OKs first CAR-T for multiple myeloma
    Satyanarayana, Megha
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (12) : 13 - 13
12345